ijms-logo

Journal Browser

Journal Browser

Molecular Advances of Mass Spectrometry in Rapid Cancer Detection and Treatment

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Informatics".

Deadline for manuscript submissions: 30 July 2024 | Viewed by 1118

Special Issue Editor


E-Mail Website
Guest Editor
Waters Research Center, 1031 Budapest, Hungary
Interests: ambient ionization mass spectrometry methods

Special Issue Information

Dear Colleagues,

Routinely using molecular information in the characterization of tumors is essential for both decision-making during surgery and in the careful selection of personalized therapies. Having real-time access to rapid molecular fingerprints of cancers in the operating rooms to assist decision-making during cancer surgeries is part of our current and future vision. This information—if available in a short time frame during cancer surgery—can have a significant impact on the outcomes and re-operation rates. In the future of automated, robotic surgery, real-time molecular information is also essential in the precise guidance of surgical robots. In parallel, easily accessible molecular information for pathologists can also support the rapid, detailed subtyping of the tumors and the suggested point-of-care therapies. Modern applications of mass spectrometry have enabled the collection of rapid, in vitro, even in vivo molecular data that is easily accessible to anyone. The interpretation of the gained molecular fingerprints, including small metabolites, lipids, peptides and proteins and linking the observed molecular patterns to known cancerous cell mechanisms is essential in our understanding of the role of mass spectrometry in cancer detection. This Special Issue on ‘Molecular Advances of Mass Spectrometry in Rapid Cancer Detection and Treatment’ invites original research and reviews on all aspects of novel and rapid mass spectrometry-based molecular information collection, interpretation of known cancer mechanisms and supporting computational technologies, and machine learning in cancer detection and subtyping.

Dr. Julia Balog
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • mass spectrometry in cancer detection
  • mass spectrometry in personalized cancer therapies
  • mass spectrometry in future operating rooms
  • cancer metabolomics, lipidomics and proteomics using mass spectrometry
  • real-time tissue identification using mass spectrometry, cancer subtyping using mass spectrometry

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

24 pages, 2106 KiB  
Review
A Workflow for Meaningful Interpretation of Classification Results from Handheld Ambient Mass Spectrometry Analysis Probes
by Alexa Fiorante, Lan Anna Ye, Alessandra Tata, Taira Kiyota, Michael Woolman, Francis Talbot, Yasamine Farahmand, Darah Vlaminck, Lauren Katz, Andrea Massaro, Howard Ginsberg, Ahmed Aman and Arash Zarrine-Afsar
Int. J. Mol. Sci. 2024, 25(6), 3491; https://doi.org/10.3390/ijms25063491 - 20 Mar 2024
Cited by 1 | Viewed by 653
Abstract
While untargeted analysis of biological tissues with ambient mass spectrometry analysis probes has been widely reported in the literature, there are currently no guidelines to standardize the workflows for the experimental design, creation, and validation of molecular models that are utilized in these [...] Read more.
While untargeted analysis of biological tissues with ambient mass spectrometry analysis probes has been widely reported in the literature, there are currently no guidelines to standardize the workflows for the experimental design, creation, and validation of molecular models that are utilized in these methods to perform class predictions. By drawing parallels with hurdles that are faced in the field of food fraud detection with untargeted mass spectrometry, we provide a stepwise workflow for the creation, refinement, evaluation, and assessment of the robustness of molecular models, aimed at meaningful interpretation of mass spectrometry-based tissue classification results. We propose strategies to obtain a sufficient number of samples for the creation of molecular models and discuss the potential overfitting of data, emphasizing both the need for model validation using an independent cohort of test samples, as well as the use of a fully characterized feature-based approach that verifies the biological relevance of the features that are used to avoid false discoveries. We additionally highlight the need to treat molecular models as “dynamic” and “living” entities and to further refine them as new knowledge concerning disease pathways and classifier feature noise becomes apparent in large(r) population studies. Where appropriate, we have provided a discussion of the challenges that we faced in our development of a 10 s cancer classification method using picosecond infrared laser mass spectrometry (PIRL-MS) to facilitate clinical decision-making at the bedside. Full article
Show Figures

Figure 1

Back to TopTop